Dr Kella is a fellowship-trained urologist in oncology. In 2009, He performed more robotic prostatectomies than anyone else in Texas. He ranks among the top 10 robotic prostate cancer specialists in the United States.


About Dr Kella


Dr Kella completed a degree in Chemical Engineering from Stanford University and went on to receive his MD degree from University of Texas at Southwestern Medical School in Dallas, TX. After finishing residency at Tufts University in Boston, MA, he went on for further fellowship training at Baylor School of Medicine in Houston, TX to develop expertise in urological oncology and robotic surgery.



After his training, Dr Kella came to Urology San Antonio and performed the area's first robotic prostatectomy for prostate cancer and radical cystectomy for bladder cancer. He has performed over 1500 cases for prostate cancer, making him one of the most experienced surgeons in the nation. (Click here to learn about the importance of experience.) In 2009, Dr Kella performed more robotic prostate surgeries than anyone else in Texas, according to Intuitive Surgical. He is Director of Robotic Surgery and Assistant Director of Research at Urology San Antonio and served as Chief of Surgery at St Lukes Baptist Medical Center in San Antonio, TX. His routine is to perform 6 to 10 cases per week, with the same team at the same hospital.He is principal investigator on numerous clinical studies and has been involved in the study of many novel agents for prostate cancer including Protox, ZD4054, and GVAX.  He has consulted for companies such as AMS and Intuitive Surgical.
He also has contributed to the literature in prostate cancer.

He is committed to making the patient experience as painless and as successful as possible.

In his spare time, he enjoys time with his family. playing sports, and working with new tech tools and gadgets.

Frequently Asked Questions

Hospital Stay Beyond Two Nights for Robotic Assisted Laparoscopic Prostatectomy



The following abstract was accepted for presentation at the International Robotic Urology Society meeting in Las Vegas for 2010.

Hospital Stay Beyond Two Nights for Robotic Assisted Laparoscopic Prostatectomy
Kusuma Kurmayagari MD, Naveen Kella MD
San Antonio, TX

In experienced hands, robotic assisted laparoscopic prostatectomy generally results in quick discharge home. Reasons for hospital stay beyond 2 days are examined from electronic hospital data from a single-surgeon series of 707 consecutive cases from April 2007 to September 2009 at a community-based institution. The surgeon had performed over 700 cases previously within a different system. A transperitoneal technique using the Montsouris approach was used. Criteria for discharge include pain control on oral medication, ability to ambulate and tolerate a regular diet and to be medically stable. Drains were removed prior to discharge in the vast majority, except in cases of increased drainage after a lymph node dissection. No open conversions were performed. 72% of patients were discharged after one night in the hospital. 21% were discharged after two nights in the hospital. The most common diagnosis for stay beyond two nights was ileus in 10 of the 34 patients (1.4%). The second most common reason was nonmedical in 7 of 34 patients. Post operative anemia requiring blood transfusion occurred in 4 patients (0.5%). Heavy drainage due to a urinoma was noted in one patient who was discharged drain free after 4 nights. The longest hospitalization was for 28 days due to unrecognized bowel perforation during adhesolysis. This was the only patient requiring a return to the operating room. No thromboembolic events or deaths were noted. Robotic prostatectomy can be a procedure with acceptable complication rates during the post-operative period, making the procedure suitable for an community-based practice.